An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma

NAActive, not recruitingINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 6, 2021

Primary Completion Date

April 6, 2026

Study Completion Date

April 6, 2026

Conditions
Pancreas CancerGastrointestinal Adenocarcinoma
Interventions
DIAGNOSTIC_TEST

ultrasound

Participants will undergo research ultrasound (rUS1) within three days of their routine CECT scan. A subset of participants (up to 10) will undergo a second research US (rUS2) at 3-4 weeks after rUS1 and at least one month prior to the next planned clinical CECT

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER